Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
05/1998
05/20/1998EP0841941A1 Novel non-pyrogenic bacterial strains and use of the same
05/20/1998EP0841935A1 Modulation of endothelial cell proliferation
05/20/1998CN1182454A DNA molecule encoding for cellular uptake of mycobacterium tuberculosis and uses thereof
05/20/1998CN1182452A Osteoprotegerine
05/19/1998US5753613 Drug delivery using a complexes containing an ammonium quaternary compound and lipid; transfection
05/19/1998US5753505 Genetic expressing a marker, cell differentiation for treating nervous system disorder, alzheimer's disease
05/19/1998US5753499 Viral vector complexes having adapters of predefined valence
05/19/1998US5753491 Use of neuro-derived fetal cell lines for transplantation therapy
05/19/1998US5753480 Cysteinyl tRNA synthetase polynucleotides of streptococcus
05/19/1998US5753479 Genetic enginnering
05/19/1998US5753476 Identification of a human cytomegalovirus gene region involved in down regulation of MHC class I heavy chain expression
05/19/1998US5753446 Mitogen ERK kinase kinase (MEKK) assay
05/19/1998US5753441 Genetic engineering
05/19/1998US5753432 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells
05/19/1998US5753263 Method to deliver compositions conferring resistance to alopecia to hair follicles
05/19/1998US5753262 Transmembrane compatible body for transfection of animal cells with nucleotides
05/19/1998US5753238 Target antigens of transmission blocking antibodies for malaria parasites
05/19/1998US5753220 Cysteine protease gene defective baculovirus, process for its production, and process for the production of economic protein by using the same
05/19/1998CA2190679A1 Lymphocyte tachykinin
05/14/1998WO1998020161A1 Methods for identifying genes essential to the growth of an organism
05/14/1998WO1998020146A2 Stabilized transient gene expression
05/14/1998WO1998020137A1 Human squalene epoxidase
05/14/1998WO1998020131A1 Glaucoma-associated protein and corresponding nucleic acid and their therapeutic and diagnostic uses
05/14/1998WO1998020127A1 Guanine exchange factor of rho gtpase and nucleic acid encoding it
05/14/1998WO1998020124A2 Diabetes-mediating proteins and therapeutic uses thereof
05/14/1998WO1998020109A1 Pressure-mediated intracellular delivery of molecules or microparticles
05/14/1998WO1998020032A1 Sprouty protein and coding sequence
05/14/1998WO1998020027A2 Therapeutic use of an agent that stimulates no or prostacyclin production and delivery device
05/14/1998WO1998020023A1 Therapeutic and diagnostic agents capable of modulating cellular responsiveness to cytokines
05/14/1998WO1998020016A1 Novel coding sequences from herpes simplex virus type-2
05/14/1998WO1998019712A1 Methods for regulating angiogenesis
05/14/1998WO1998019711A1 Peptides for gene delivery
05/14/1998WO1998019710A2 Delivery of nucleic acid material to target cells in biological systems
05/14/1998WO1998019709A2 Cationic reagents for transfection
05/14/1998WO1998019701A1 Methods for promoting wound healing and treating transplant-associated vasculopathy
05/14/1998WO1998019695A1 Device and method for delivery of erythropoietin
05/14/1998WO1998019691A1 Dominant negative mutants of irs-1 and uses thereof
05/14/1998WO1998019689A1 Novel coding sequences
05/14/1998WO1998019540A1 In vivo selection of primitive hematopoietic cells
05/14/1998WO1998010085A3 Gene therapy for congestive heart failure
05/14/1998WO1998007859A3 Secreted proteins and polynucleotides encoding them
05/14/1998WO1998006864A3 Spatial and temporal control of gene expression using a heat shock protein promoter in combination with local heat
05/14/1998WO1998005776A3 Secreted proteins and polynucleotides encoding them
05/14/1998WO1998004286A3 Assembly-deficient herpesvirus vaccine
05/14/1998WO1998001162A3 Gene delivery system
05/14/1998WO1998000172A3 Compositions and methods for altering the biodistribution of biological agents
05/14/1998DE19648625A1 Mikroprojektil für das Einbringen von Substanzen in Zellen durch ballistischen Transfer Microprojectile for introducing substances into cells by ballistic transfer
05/14/1998CA2271235A1 Glaucoma-associated protein and corresponding nucleic acid and their therapeutic and diagnostic uses
05/14/1998CA2271006A1 Delivery of nucleic acid material to target cells in biological systems
05/14/1998CA2270619A1 Methods for promoting wound healing and treating transplant-associated vasculopathy
05/14/1998CA2270282A1 Novel coding sequences from herpes simplex virus type-2
05/14/1998CA2270171A1 Therapeutic and diagnostic agents capable of modulating cellular responsiveness to cytokines
05/14/1998CA2270153A1 Methods for identifying genes essential to the growth of an organism
05/14/1998CA2270137A1 Stabilized transient gene expression
05/14/1998CA2269647A1 Human squalene epoxidase
05/14/1998CA2269646A1 Diabetes-mediating proteins and therapeutic uses thereof
05/14/1998CA2269641A1 Sprouty protein and coding sequence
05/14/1998CA2263199A1 Guanine exchange factor of rho gtpase and nucleic acid encoding it
05/13/1998EP0841399A2 Mammalian fin-1 nucleic acid (a caspase) and protein sequences and uses therefor
05/13/1998EP0841396A1 Human telomerase catalytic subunit
05/13/1998EP0841394A2 Staphylococcus aureus polynucleotides, polypeptides and their uses
05/13/1998EP0840797A1 Methods and means for targeted gene delivery
05/13/1998EP0840796A2 Mucosal delivery of polynucleotides
05/13/1998EP0840791A2 Generation of immune responses to prostate-specific antigen (psa)
05/13/1998EP0840787A2 A human edg-2 receptor homolog
05/13/1998EP0840744A1 Phosphonic acid-based cationic lipids
05/13/1998EP0840743A1 Therapeutic oligonucleotides targeting the human mdr1 and mrp genes
05/13/1998EP0840741A1 Pna-dna chimeras and pna synthons for their preparation
05/13/1998EP0840623A1 A method for gene therapy using nucleic acid loaded polymeric microparticles
05/13/1998EP0840622A1 Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity
05/13/1998EP0840617A1 Therapeutic and drug screening methods for the treatment and prevention of neuronal disease
05/13/1998EP0606376B1 Method for genetically modifying bone marrow cells of primates, and useful cells therefor that produce recombinant retroviral vectors
05/13/1998CN1181706A Arteriovenous and venous graft treatments: methods and compsns.
05/13/1998CN1181704A Use of glial neurotrophic factor (GDND) for treatment of hearing disorders
05/13/1998CN1181422A Gene transfer carrier structured by polypeptide in conjunction with growth factor receptor
05/12/1998US5750692 Alkylating cyano-1-(3,5-di-o-p-toluoyl-beta-d-pentose)imidazole in base, ammonolyating, cyclizing
05/12/1998US5750653 Protein, FAF1, which potentiates Fas-mediated apoptosis and uses thereof
05/12/1998US5750571 Methods and therapeutic compositions for treating cystic fibrosis
05/12/1998US5750400 Coding sequences of the human BRCA1 gene
05/12/1998US5750398 Vector, element and method for inhibiting immune recognition
05/12/1998US5750396 Stable virus packaging cell lines
05/12/1998US5750395 DNA encoding MAGE-1 C-terminal cytotoxic t lymphocyte immunogenic peptides
05/12/1998US5750391 Filariid nematode cysteine protease proteins
05/12/1998US5750387 DNA encoing leucyl TRNA synthetase from staphylococcus aureus
05/12/1998US5750376 In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny
05/12/1998US5750103 Method for transplanting cells into the brain and therapeutic uses therefor
05/12/1998US5750102 Double transfectants of the MHC genes as cellular vaccines for immuno prevention of tumor metastasis
05/12/1998US5749847 Delivery of nucleotides into organisms by electroporation
05/07/1998WO1998018960A1 Process aimed at evidencing the state of a malignant cell and process for treatment
05/07/1998WO1998018951A1 Receptor-mediated gene transfer system for targeting tumor gene therapy
05/07/1998WO1998018950A2 Aav-dna helper virus sequences
05/07/1998WO1998018934A1 Therapeutic gene
05/07/1998WO1998018931A2 Streptococcus pneumoniae polynucleotides and sequences
05/07/1998WO1998018930A2 Streptococcus pneumoniae antigens and vaccines
05/07/1998WO1998018926A1 Circularly permuted erythropoietin receptor agonists
05/07/1998WO1998018925A2 Modified glucocorticoid receptors, glucocorticoid receptors/progesterone receptors hybrids
05/07/1998WO1998018924A1 Circularly permuted polypeptides as novel stem cell factor receptor agonists
05/07/1998WO1998018923A1 NOVEL flt-3 RECEPTOR AGONISTS
05/07/1998WO1998018921A1 NEUTROKINE $g(a)
05/07/1998WO1998018918A1 Stable expression of triple helical proteins
1 ... 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 ... 870